Next Article 
Clinical Microbiology Reviews, January 2004, p. 1-13, Vol. 17, No. 1
0893-8512/04/$08.00+0 DOI: 10.1128/CMR.17.1.1-13.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Neonatal Herpes Simplex Infection
David W. Kimberlin*
Division of Pediatric Infectious Diseases, The University of Alabama at Birmingham, Birmingham, Alabama 35233
Tremendous advances have occurred over the past 30 years in the diagnosis and management of neonatal herpes simplex virus (HSV) disease. Mortality in patients with disseminated disease has decreased from 85 to 29%, and that in patients with central nervous system (CNS) disease has decreased from 50 to 4%. Morbidity has been improved more modestly: the proportion of patients with disseminated disease who are developing normally at 1 year has increased from 50 to 83%. While the proportion of patients with neurologic morbidity following CNS disease has remained essentially unchanged over the past three decades, the total number of patients who are developing normally following HSV CNS disease has increased due to the improved survival. Although additional therapeutic advances in the future are possible, more immediate methods for further improvements in outcome for patients with this potentially devastating disease lie in an enhanced awareness of neonatal HSV infection and disease. A thorough understanding of the biology and natural history of HSV in the gravid woman and the neonate provides the basis for such an index of suspicion and is provided in this article.
* Mailing address: Division of Pediatric Infectious Diseases, The University of Alabama at Birmingham, 1600 Seventh Ave. South, CHB 303, Birmingham, AL 35233. Phone: (205) 996-7802. Fax: (205) 975-9972. E-mail:
dkimberlin{at}peds.uab.edu
Clinical Microbiology Reviews, January 2004, p. 1-13, Vol. 17, No. 1
0893-8512/04/$08.00+0 DOI: 10.1128/CMR.17.1.1-13.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Meda, M., Godden, C., Irish, D.
(2009). Herpetic neonatal pustular rash. BMJ Case Reports
2009: bcr1020081149-bcr1020081149
[Abstract]
[Full Text]
-
Muller, W. J., Dong, L., Vilalta, A., Byrd, B., Wilhelm, K. M., McClurkan, C. L., Margalith, M., Liu, C., Kaslow, D., Sidney, J., Sette, A., Koelle, D. M.
(2009). Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection. J. Gen. Virol.
90: 1153-1163
[Abstract]
[Full Text]
-
Cattamanchi, A., Posavad, C. M., Wald, A., Baine, Y., Moses, J., Higgins, T. J., Ginsberg, R., Ciccarelli, R., Corey, L., Koelle, D. M.
(2008). Phase I Study of a Herpes Simplex Virus Type 2 (HSV-2) DNA Vaccine Administered to Healthy, HSV-2-Seronegative Adults by a Needle-Free Injection System. CVI
15: 1638-1643
[Abstract]
[Full Text]
-
Rietmeijer, C. A, Low, N.
(2008). Herpes complex. Sex. Transm. Infect.
84: 330-331
[Full Text]
-
Tan, E., Erwin, B., Dames, S., Voelkerding, K., Niemz, A.
(2007). Isothermal DNA amplification with gold nanosphere-based visual colorimetric readout for herpes simplex virus detection.. Clin. Chem.
53: 2017-2020
[Full Text]
-
O'Riordan, D. P., Golden, W. C., Aucott, S. W.
(2006). Herpes Simplex Virus Infections in Preterm Infants. Pediatrics
118: e1612-e1620
[Abstract]
[Full Text]
-
Haddow, L J, Dave, B, Mindel, A, McPhie, K A, Chung, C, Marks, C, Dwyer, D E
(2006). Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003.. Sex. Transm. Infect.
82: 255-259
[Abstract]
[Full Text]
-
Kropp, R. Y., Wong, T., Cormier, L., Ringrose, A., Burton, S., Embree, J. E., Steben, M.
(2006). Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study.. Pediatrics
117: 1955-1962
[Abstract]
[Full Text]